SEC Filings TLDR

Daktronics, Inc. (the 'Company') reported significant leadership changes and equity awards in its Form 8-K filing dated July 28, 2025. Sheila M. Anderson, the Company’s Chief Data and Analytics Officer, ceased to hold the designation of principal accounting officer, effective immediately. Howard I. Atkins, the Company’...

On August 1, 2025, Casella Waste Systems, Inc. (the 'Company') successfully closed the remarketing of $29.0 million aggregate principal amount of the Finance Authority of Maine Solid Waste Disposal Revenue Bonds, originally issued in 2015 and 2018. The Bonds were remarketed as a single series designated as Series 2015R...

Casella Waste Systems, Inc. has announced the pricing of the remarketing of $29.0 million aggregate principal amount of Finance Authority of Maine Solid Waste Disposal Revenue Bonds. The Bonds, originally issued in the aggregate principal amount of $30.0 million, have a final maturity of August 1, 2035. It is expected ...

CaliberCos Inc. (NASDAQ: CWD) announced on July 30, 2025, that it will release its second quarter 2025 financial results after the market closes on Wednesday, August 13, 2025. The company will host a webcast/conference call at 5:00 pm ET on the same day to discuss the results. Investors can access the call by dialing (...

CytoSorbents Corporation (NASDAQ: CTSO) has issued a press release on July 31, 2025, detailing new studies that demonstrate the effectiveness of CytoSorb® therapy in treating sepsis and septic shock. The company emphasizes the importance of early and intensive use of CytoSorb to improve clinical outcomes. CytoSorbents ...

America's Car-Mart Inc. received a notice from Nasdaq on July 31, 2025, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 10-K for the fiscal year ended April 30, 2025. The delay was attributed to the need for additional disclosures related to loan modi...

CPS Technologies Corporation announced its financial results for the second quarter of 2025, reporting record revenue of $8.1 million, a significant increase from $5.0 million in the prior-year period. The company achieved a gross margin of 16.5%, compared to a gross loss in the previous year, and posted an operating p...

On July 31, 2025, Charter Communications, Inc. held a special meeting of stockholders to vote on proposals related to the Transaction Agreement with Cox Communications, Inc. The proposals included the issuance of new shares, amendments to the certificate of incorporation, and governance changes. The stockholders approv...

On July 21, 2025, Celularity Inc. issued a promissory note in the principal amount of $6,812,230 to an investor, along with a warrant to purchase 3,700,000 shares of Class A common stock at $2.528 per share. The note bears an interest rate of 2% per annum and matures on March 21, 2026. The note is secured by a security...

Celcuity Inc. has entered into an underwriting agreement to issue and sell $201.25 million in aggregate principal amount of its 2.750% Convertible Senior Notes due 2031. The notes were sold in a public offering, with the underwriters exercising their option to purchase an additional $26.25 million in notes. The notes w...

CEA Industries Inc. commenced a private placement offering on July 28, 2025, as disclosed in their Form 8-K filing. The offering involved the sale of 41,754,478 shares of common stock at $10.10 per share, pre-funded warrants to purchase up to 7,750,510 shares of common stock at $10.09999 per warrant, and stapled warran...

Heritage Distilling Holding Company Inc. (the 'Company') filed a Form 8-K on July 31, 2025, reporting the sale of Common Stock to C/M Capital Master Fund, LP (the 'Investor') under a previously disclosed Purchase Agreement. Between February 19, 2025, and July 30, 2025, the Company sold an aggregate of 11,962,810 shares...

BrightSpring Health Services, Inc. reported its financial results for the second quarter of 2025, showing significant growth in key metrics. The company announced a net revenue of $3,148 million, a 29.1% increase compared to the same period in 2024. Adjusted EBITDA also rose by 28.8% to $143 million. The company highli...

BTCS Inc. filed a Current Report on Form 8-K to include the legal opinion of Nason, Yeager, Gerson, Harris & Fumero, P.A. regarding the validity of the company's common stock shares that may be issued under its at-the-market offering program. The legal opinion, filed as Exhibit 5.1, confirms that the shares are duly au...

BioXcel Therapeutics, Inc. announced the completion of the last patient visit in the SERENITY At-Home Pivotal Phase 3 Safety Trial for the acute treatment of agitation associated with bipolar disorders or schizophrenia. The trial, which enrolled over 200 patients across 22 sites nationwide, evaluated the safety of a 12...

On July 30, 2025, BioMarin Pharmaceutical Inc. announced the appointment of Ian T. Clark to its Board of Directors, effective August 1, 2025. The Board size was increased from ten to eleven members to accommodate this appointment. Mr. Clark will serve on the Audit Committee and the Science and Technology Committee. As ...

BayFirst Financial Corp. reported a net loss of $1.2 million for the second quarter of 2025, driven by higher provision expenses and write-downs on SBA 7(a) loans. The company is undergoing a strategic review to de-risk unguaranteed SBA 7(a) balances and position itself for long-term growth. The Board has suspended div...

AYRO, Inc. announced the declaration of a dividend of one preferred share purchase right (a 'Right') for each outstanding share of Company Stock. The dividend is payable on August 11, 2025, to stockholders of record as of the close of business on August 11, 2025. Each Right initially entitles the holder to purchase one...

Amneal Pharmaceuticals, Inc. reported on August 1, 2025, that its subsidiary, Amneal Pharmaceuticals LLC, entered into significant financing transactions totaling $2.7 billion. This includes a $2.1 billion new seven-year term B loan and a $600 million offering of 6.875% senior secured notes due 2032. The proceeds were ...

Alzamend Neuro, Inc. (the 'Company') reported the issuance of 243,429 shares of common stock, par value $0.0001 per share, upon the conversion of approximately 564.76 shares of Series B Convertible Preferred Stock. This transaction occurred between July 23, 2025, and July 30, 2025. The shares were issued in reliance on...

Allogene Therapeutics, Inc. has selected standard fludarabine and cyclophosphamide (FC) as the lymphodepletion regimen for its ALPHA3 study evaluating cemacabtagene ansegedleucel (cema-cel) in first-line consolidation for large B-cell lymphoma (LBCL). This decision was made in consultation with the ALPHA3 Data and Safe...

On July 31, 2025, Airship AI Holdings, Inc. (the 'Company') updated the charters of its Audit Committee, Compensation Committee, and Nominations and Corporate Governance Committee. These updates were part of the Company's periodic review process. The updated charters were adopted by the Company's board of directors and...

On July 29, 2025, Philip Bodie resigned from his position as Chief Accounting Officer at AirSculpt Technologies, Inc., effective August 1, 2025. The resignation was reported in a Form 8-K filing with the SEC. The filing did not provide additional details regarding the reasons for Bodie's departure or any immediate plan...

AirSculpt Technologies, Inc. reported its financial results for the second quarter of fiscal year 2025, ending June 30, 2025. The company experienced a 13.7% decline in revenue to $44.0 million compared to the same period in 2024, with a net loss of $0.6 million, an improvement from the $3.2 million net loss in Q2 2024...

On July 29, 2025, Senmiao Technology Limited received a deficiency notice from The Nasdaq Stock Market indicating that its common stock failed to meet the $1 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice, based on the closing bid price for the preceding 30 consecutive busi...